60 Degrees Pharmaceuticals Inc

Research 60 Degrees Pharmaceuticals Inc (SXTP) on Bullrun: market cap USD 4.73M. Explore financials, valuation history, model signals, and stock context.

Key Metrics

• TickerSXTP
• ExchangeNASDAQ
• CountryUnited States
• SectorHealthcare
• IndustryBiotechnology
• CurrencyUSD
• Market capUSD 4.73M
• Financial periodFY2025
• RevenueUSD 1.01M
• Revenue growth65.5%
• Net income-USD 7.37M
• Free cash flow-USD 6.99M
• Gross margin22.3%

Valuation Snapshot

latest market cap is USD 4.73M.

About 60 Degrees Pharmaceuticals Inc

60 Degrees Pharmaceuticals, Inc., a specialty pharmaceutical company, engages in the development and commercialization of therapies for the prevention and treatment of infectious diseases in the United States. It offers Arakoda for malaria prevention treatment. The company also engages in the development of Tafenoquine (Arakoda regimen) that is in Phase IIb clinical trial for COVID-19 indications;

Frequently asked questions

What is 60 Degrees Pharmaceuticals Inc's market cap?

60 Degrees Pharmaceuticals Inc's market capitalization is USD 4.73M.

What does 60 Degrees Pharmaceuticals Inc do?

60 Degrees Pharmaceuticals, Inc., a specialty pharmaceutical company, engages in the development and commercialization of therapies for the prevention and treatment of infectious diseases in the United States. It offers Arakoda for malaria prevention treatment.